Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Raharja Energi Cepu Tbk. (RATU) vs Organon Pharma Indonesia Tbk. (SCPI)

Raharja Energi Cepu Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Raharja Energi Cepu Tbk. dan Organon Pharma Indonesia Tbk.: Raharja Energi Cepu Tbk. diperdagangkan di Rp4.580 (kapitalisasi pasar 12,49 T, volume 24 jam 11,44 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Raharja Energi Cepu Tbk. jauh lebih besar — sekitar 119,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

RATUSCPI
Kapitalisasi Pasar
12,49 T104,4 M
Volume
11,44 jt
Lot
114,36 rb
Perputaran
53,23 M
Harga Rata-rata
4.654,9
Nilai Transaksi
53,23 M
Harga Ekuilibrium Indikatif
4.580
Volume Ekuilibrium Indikatif
2,62 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

RATU
Lihat detail
SCPI
Lihat detail

Tentang Raharja Energi Cepu Tbk.

PT Raharja Energi Cepu Tbk (the Company) was established under the name of PT Syabas Usaha Migas on October 16, 2006 based on notarial deed No. 07 of Indah Setyaningsih, S.H. The Company incorporated in the business group of PT Rukun Raharja Tbk. The Company's ultimate parent entity is PT Rukun Raharja Tbk.

Selengkapnya di halaman RATU

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI